Harmony Sciences shares plunged Wednesday after the FDA rejected its bread-and-butter drug as a treatment for a daytime sleepiness condition.

The results were stunning. So too was the nationality of the company behind them. Akeso, a biotech firm, is Chinese.

Conagra is facing significant operational challenges, but the valuation is now compelling enough to reward buyers despite the ...

Medtronic stock skidded Tuesday after the medtech giant missed sales expectations, though profit came in well ahead of forecasts.

B.C.'s NDP government laid out its priorities for 2025 amid a backdrop of looming U.S. trade tariffs and a record-high ...

Experience SXSW 2025 in Austin, March 7–15—tech, film, music & more. Now expanding with SXSW Sydney & London. Register now!

Nexus Pharmaceuticals, LLC announces the U.S Food and Drug Administration (FDA) approval of Tacrolimus Injection 5 mg/mL. Nexus’ Tacrolimus Injection is the first and only vial that will be available.

Email: n.venegas@newsweek.com President Donald Trump administration's push to downsize the federal government has reached the U.S. Food and Drug Administration (FDA), resulting in layoffs that ...

Dupixent sBLA accepted for FDA priority review for the targeted treatment of bullous pemphigoid If approved, Dupixent would be the first and only targeted medicine to treat BP in the US; FDA decision ...

The U.S. Food and Drug Administration has made an update to its MadeGood granola bar recall. The popular granola bars, sold on Amazon and in stores like Target, Whole Foods, Wegmans, CVS ...

Piper Sandler analyst Yasmeen Rahimi initiated coverage with a Buy rating on Bright Minds Biosciences (DRUG – Research Report) today and set a price target of $93.00. The company’s shares ...

Mesoblast Limited (Nasdaq:MESO; ASX:MSB), a global leader in allogeneic cellular medicines for inflammatory diseases, today ...